/ISRG
ISRG Stock - Intuitive Surgical, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$572.47+1.88%
+$10.58 (+1.88%) • Dec 19
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.78
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).63
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.53
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+6.4%upside
Target: $609.11
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ISRG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$566.75 – $578.19
TARGET (TP)$608.92
STOP LOSS$526.67
RISK/REWARD1:0.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.69
52W High$616.00
52W Low$425.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B |
| Gross Profit | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B |
| Gross Margin | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% |
| Operating Income | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B |
| Net Income | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B |
| Net Margin | 27.8% | 25.2% | 21.3% | 29.9% | 24.3% |
| EPS | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 |
Company Overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
15
68%
Hold / Neutral
6
27%
Sell / Underperform
1
5%
Analyst Consensus🟡 Mixed
15 Bullish7 Neutral/Bearish
Price Targets
$359
Average Target
↓ 37.3% Downside
Now
$210
Low
$359
Average
$650
High
Based on 25 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 11th 2025 | Citigroup | Downgrade | Neutral | $635 |
| July 23rd 2025 | Erste Group | Downgrade | Hold | - |
| June 9th 2025 | Deutsche Bank | Downgrade | Sell | $440 |
| June 5th 2025 | Erste Group | Upgrade | Buy | - |
| December 2nd 2024 | Morgan Stanley | Upgrade | Overweight | $650← $522 |
| August 2nd 2024 | Redburn Atlantic | Upgrade | Buy | $510← $380 |
| July 10th 2024 | Citigroup | Reiterated | Buy | $512← $462 |
| May 30th 2024 | Goldman | Initiation | Buy | $500 |
| November 17th 2023 | HSBC Securities | Initiation | Buy | $318 |
| July 19th 2023 | Robert W. Baird | Initiation | Outperform | $377 |
| April 19th 2023 | Evercore ISI | Reiterated | In-line | $270← $240 |
| April 19th 2023 | Citigroup | Reiterated | Buy | $317← $305 |
| April 19th 2023 | BTIG Research | Reiterated | Buy | $313← $284 |
| April 19th 2023 | Stifel | Reiterated | Buy | $315← $285 |
| April 19th 2023 | Truist | Reiterated | Buy | $325← $300 |
Earnings History & Surprises
ISRGBeat Rate
89%
Last 18 quarters
Avg Surprise
+8.9%
EPS vs Estimate
Beats / Misses
16/2
Last 12 quarters
Latest EPS
$2.40
Q4 2025
EPS Surprise History
Q1 24
+8.1%
$1.60vs$1.48
Q2 24
+6.4%
$1.50vs$1.41
Q3 24
+15.6%
$1.78vs$1.54
Q4 24
+12.9%
$1.84vs$1.63
Q1 25
+25.6%
$2.21vs$1.76
Q2 25
+4.0%
$1.81vs$1.74
Q3 25
+13.5%
$2.19vs$1.93
Q4 25
+20.6%
$2.40vs$1.99
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 20, 2026 | — | — | — | — |
Q1 2026 | Jan 22, 2026 | $2.25 | — | — | — |
Q4 2025 | Oct 21, 2025 | $1.99 | $2.40 | +20.6% | ✓ BEAT |
Q3 2025 | Jul 22, 2025 | $1.93 | $2.19 | +13.5% | ✓ BEAT |
Q2 2025 | Apr 22, 2025 | $1.74 | $1.81 | +4.0% | ✓ BEAT |
Q1 2025 | Jan 23, 2025 | $1.76 | $2.21 | +25.6% | ✓ BEAT |
Q4 2024 | Oct 17, 2024 | $1.63 | $1.84 | +12.9% | ✓ BEAT |
Q3 2024 | Jul 18, 2024 | $1.54 | $1.78 | +15.6% | ✓ BEAT |
Q2 2024 | Apr 18, 2024 | $1.41 | $1.50 | +6.4% | ✓ BEAT |
Q1 2024 | Jan 23, 2024 | $1.48 | $1.60 | +8.1% | ✓ BEAT |
Q4 2023 | Oct 19, 2023 | $1.41 | $1.46 | +3.5% | ✓ BEAT |
Q3 2023 | Jul 20, 2023 | $1.33 | $1.42 | +6.8% | ✓ BEAT |
Q2 2023 | Apr 18, 2023 | $1.20 | $1.23 | +2.5% | ✓ BEAT |
Q1 2023 | Jan 24, 2023 | $1.26 | $1.23 | -2.4% | ✗ MISS |
Q4 2022 | Oct 18, 2022 | $1.10 | $1.19 | +8.2% | ✓ BEAT |
Q3 2022 | Jul 21, 2022 | $1.16 | $1.14 | -1.7% | ✗ MISS |
Q2 2022 | Apr 21, 2022 | $1.08 | $1.13 | +4.6% | ✓ BEAT |
Q1 2022 | Jan 20, 2022 | $1.28 | $1.30 | +1.6% | ✓ BEAT |
Q4 2021 | Oct 19, 2021 | $1.17 | $1.19 | +1.7% | ✓ BEAT |
Q3 2021 | Jul 20, 2021 | $1.02 | $1.31 | +28.4% | ✓ BEAT |
Latest News
CNBC Halftime Report Final Trades: Toast, Dick's Sporting Goods, Intuitive Surgical
➖ NeutralBenzinga•Dec 18, 2025, 06:00 PM•Also:
Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $650
📈 PositiveBenzinga•Dec 18, 2025, 02:29 PM
RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $650
📈 PositiveBenzinga•Dec 17, 2025, 01:17 PM
Live On CNBC, Kevin Simpson Announces Bought Intuitive Surgical
📈 PositiveBenzinga•Dec 12, 2025, 05:29 PM
Citigroup Downgrades Intuitive Surgical to Neutral, Lowers Price Target to $635
➖ NeutralBenzinga•Dec 11, 2025, 02:01 PM•Also:
Intuitive Says FDA Clears da Vinci Single Port Surgical System For Use In Inguinal Hernia Repair, Cholecystectomy, And Appendectomy Procedures
📈 PositiveBenzinga•Dec 10, 2025, 09:20 PM
Live On CNBC, Bill Baruch Announces Bought Intuitive Surgical
📈 PositiveBenzinga•Dec 1, 2025, 05:47 PM
The Motley Fool Analysts Andy Cross, Emily Flippen, and Jason Moser on How Tariffs Are Impacting Intuitive Surgical's Profits Right Now
📉 NegativeThe Motley Fool•Nov 13, 2025, 02:00 AM
UBS Maintains Neutral on Intuitive Surgical, Raises Price Target to $600
➖ NeutralBenzinga•Oct 23, 2025, 09:25 PM•Also:
Intuitive Surgical shares are trading higher on continued strength after the company recently reported better-than-expected Q3 financial results.
📈 PositiveBenzinga•Oct 23, 2025, 04:27 PM
Intuitive Surgical poised for future growth as da Vinci 5 ramps up
📈 PositiveSeeking Alpha•Oct 22, 2025, 05:23 PM
Benzinga Market Summary: S&P Falls As Texas Instruments And Netflix Drop, US Government Shutdown Enters 22nd Day, Intuitive Surgical Rises On Earnings Beat
📉 NegativeBenzinga•Oct 22, 2025, 04:15 PM•Also: ,
Raymond James Maintains Outperform on Intuitive Surgical, Raises Price Target to $603
📈 PositiveBenzinga•Oct 22, 2025, 03:58 PM
Piper Sandler Reiterates Overweight on Intuitive Surgical, Raises Price Target to $610
📈 PositiveBenzinga•Oct 22, 2025, 03:28 PM
RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $625
📈 PositiveBenzinga•Oct 22, 2025, 02:21 PM
Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $620
📈 PositiveBenzinga•Oct 22, 2025, 02:03 PM
Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $600
📈 PositiveBenzinga•Oct 22, 2025, 01:29 PM
BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $589
📈 PositiveBenzinga•Oct 22, 2025, 11:19 AM
Market-Moving news for October 22nd
➖ NeutralBenzinga•Oct 22, 2025, 11:11 AM•Also: ,
Intuitive Surgical shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveBenzinga•Oct 22, 2025, 10:40 AM
Frequently Asked Questions about ISRG
What is ISRG's current stock price?
Intuitive Surgical, Inc. (ISRG) is currently trading at $572.47 per share. The stock has moved +1.88% today.
What is the analyst price target for ISRG?
The average analyst price target for ISRG is $608.92, based on 1 analyst.
What sector is Intuitive Surgical, Inc. in?
Intuitive Surgical, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is ISRG's market cap?
Intuitive Surgical, Inc. has a market capitalization of $204.50 billion, making it a mega-cap company.
Does ISRG pay dividends?
No, Intuitive Surgical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBAX
Baxter International Inc.
$18.96
Mkt Cap: $9.7B
BDX
Becton, Dickinson and Company
$195.59
Mkt Cap: $56.3B
BNGO
Bionano Genomics, Inc.
$1.60
Mkt Cap: $0.0B
COO
The Cooper Companies, Inc.
$82.75
Mkt Cap: $16.5B
EMBC
Embecta Corp.
$11.75
Mkt Cap: $0.7B
HOLX
Hologic, Inc.
$74.95
Mkt Cap: $16.7B
ICUI
ICU Medical, Inc.
$145.15
Mkt Cap: $3.6B
LUCY
Innovative Eyewear, Inc.
$1.38
Mkt Cap: $0.0B
MMSI
Merit Medical Systems, Inc.
$87.70
Mkt Cap: $5.2B
NXGL
NEXGEL, Inc.
$1.62
Mkt Cap: $0.0B
Explore stocks similar to ISRG for comparison